Sarthak Metals Ltd ( ($IN:SMLT) ) has issued an update. Sarthak Metals Ltd has announced amendments to its Memorandum of Association, following ...

CSL Ltd (ASX: CSL) shares have gotten walloped since August. Is the ASX 200 biotech giant now a bargain buy or one to steer ...

Management has positioned bezuclastinib as a potential alternative to Blueprint Medicines' (BPMT) Ayvakit. This PDGFRα/c-KIT ...

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

(RTTNews) - Several small-cap biotech and healthcare stocks posted notable gains in after-hours trading on Friday, November 28, 2025, despite limited fresh news flow. Below is a roundup of the key ...

But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this involves a beaten-down biotech stock that Wood has been buying regularly ...

Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through ...

Amid a challenging climate for Vancouver’s life sciences sector, Zymeworks Inc. (Nasdaq:ZYME) stands out as a success story ...

EST Moleculin Biotech (MBRX) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving ...

(RTTNews) - Biotech and healthcare stocks saw notable activity in Friday's after-hours trading session, with several names posting sharp moves on the back of corporate updates and investor ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), today announced that it filed an amendment to its amended and restated certificate of ...

Structure's aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech's stock up nearly 103% as ...